Trial Profile
Varenicline for smoking cessation in HIV-infected patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 May 2015
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Acronyms Inter-ACTIV
- 13 May 2015 New trial record